Pivotal phase 2 study of Obinutuzumab as Monotherapy or in combination with Zanubrutinib

 IMAGE   06/2020

Pivotal phase 2 study of Obinutuzumab as Monotherapy or in combination with Zanubrutinib in R/R FL

Nice to see you!

For newest details on our ESMO materials in a personal video meeting, please click here!
Service